Chronic Myeloid Leukemia Treatments

32 та иш

1. Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment

   Ekaterina Chelysheva, Anna Turkina, Evgeniya Polushkina +9

   МақолаChronic Myeloid Leukemia TreatmentsLeukemia & lymphoma/Leukemia and lymphoma20171 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.108174

2. Fostamatinib boosts QOL in RA

   МақолаChronic Myeloid Leukemia TreatmentsPharmacoEconomics & Outcomes News20110 иқтибос

   ABIABI:AkademIndex/openalex/2011.article.000596

3. 1-Methoxyficifolinol

   Shakhnoza S. Azimova, Валентина И. Виноградова

   БобChronic Myeloid Leukemia Treatments20120 иқтибос

   ABIABI:AkademIndex/openalex/2012.chapter.002509

4. Ajmaline

   Shakhnoza S. Azimova, Marat S. Yunusov

   БобChronic Myeloid Leukemia Treatments20120 иқтибос

   ABIABI:AkademIndex/openalex/2012.chapter.003051

5. Laudanidine

   Shakhnoza S. Azimova, Marat S. Yunusov

   БобFungal Plant Pathogen Control20120 иқтибос

   ABIABI:AkademIndex/openalex/2012.chapter.006348

6. Chronic Myeloid Leukemia Diagnosed during Pregnancy: Therapy, Outcomes and Follow-up

   Ekaterina Chelysheva, Elisabetta Abruzzese, Delphine Réa +9

   МақолаChronic Myeloid Leukemia TreatmentsBlood20180 иқтибос

   ABIABI:AkademIndex/openalex/2018.article.000303

7. Pregnancy Management in CML Patients: To Treat or Not to Treat? Report of 224 Outcomes of the European Leukemia Net (ELN) Database

   Elisabetta Abruzzese, Anna Turkina, Jane F. Apperley +21

   МақолаChronic Myeloid Leukemia TreatmentsBlood20190 иқтибос

   ABIABI:AkademIndex/openalex/2019.article.000226

8. PF666 LOW JAK2 V617F ALLELE BURDEN PHI‐NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS MAY ASSOCIATE WITH ADDITIONAL CALR OR MPL MUTATIONS

   Tatiana Makarik, Akmaljon Odilov, А О Абдуллаев +7

   МақолаMyeloproliferative Neoplasms: Diagnosis and TreatmentHemaSphere20190 иқтибос

   ABIABI:AkademIndex/openalex/2019.article.001242

9. Clinical observation of chronic myeloid leukemia with variant translocation and supplementary rearrangement t(1;8)(q23;q24.3)

   Yu. Yu. Assesorova, L. K. Mustafina, Saniyat Yusupova +1

   МақолаChronic Myeloid Leukemia TreatmentsRussian journal of hematology and transfusiology20210 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.009425

10. Aberrant Hydroxymethylation In Promoter Cpg Regions of Genes Related to the Cell Cycle and Apoptosis Characterizes Advanced Chronic Myeloid Leukemia Disease, Poor Imatinib Respondents And Poor Survival.

    Sameer Ahmad Guru, Mamta P. Sumi, Rashid Mir +3

    ПрепринтChronic Myeloid Leukemia TreatmentsResearch Square20210 иқтибос

    ABIABI:AkademIndex/openalex/2021.preprint.000053

11. Chronic Myeloid Leukemia Diagnosed during Pregnancy: How to Manage? Description of 86 Cases from ELN International Registry

    Ekaterina Chelysheva, Anna Turkina, Jane F. Apperley +18

    МақолаChronic Myeloid Leukemia TreatmentsBlood20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.001448

12. Use of a New Structure of Fluorescent-Labeled DNA Oligonucleotides to Reveal Mutation JAK2 V617F During Development of Leukemia

    A. A. Makhnev, A. B. Baimirzaev, Kh. Z. Nasriddinov +2

    МақолаMyeloproliferative Neoplasms: Diagnosis and TreatmentChemistry of Natural Compounds20220 иқтибос

    ABIABI:AkademIndex/openalex/2022.article.008641

13. CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management

    Bekhzodkhon Bakhodirov, Kamoliddin Olimjonov, Элдор Исхаков +7

    МақолаChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.003956

14. POSTER: CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management

    Bekhzodkhon Bakhodirov, Kamoliddin Olimjonov, Элдор Исхаков +7

    МақолаChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.010137

15. POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment

    Olga Kulemina, Julia Yakovleva, Natalia Lazorko +6

    МақолаChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.010138

16. POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial

    Jane F. Apperley, Jörge E. Cortes, Elias Jabbour +21

    МақолаChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.010140

17. POSTER: ALL-296 Results of Treatment of Children With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia With Low-dose Chemotherapy Without Bone Marrow Transplantation in Uzbekistan

    Rahmatulla Hadiyev, Ibragimova Sapura

    МақолаChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.010149

18. CML-640 Case Report of Metachronous Ph+ and Ph Myeloproliferative Neoplasms

    Kamoliddin Olimjonov, Anna Pirkhalo, Elizaveta Efremova +7

    МақолаMyeloproliferative Neoplasms: Diagnosis and TreatmentClinical Lymphoma Myeloma & Leukemia20230 иқтибос

    ABIABI:AkademIndex/openalex/2023.article.010151

19. Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry

    Ekaterina Chelysheva, Jane F. Apperley, Anna Turkina +16

    МақолаChronic Myeloid Leukemia TreatmentsLeukemia20240 иқтибос

    ABIABI:AkademIndex/openalex/2024.article.000276

20. Correction: Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry

    Ekaterina Chelysheva, Jane F. Apperley, Anna Turkina +16

    БошқаChronic Myeloid Leukemia TreatmentsLeukemia20240 иқтибос

    ABIABI:AkademIndex/openalex/2024.other.000008

21. Optimizing ibrutinib bioavailability: Formulation and assessment of hydroxypropyl-β-cyclodextrin-based nanosponge delivery systems

    Sunitha Sampathi, Nitiraj Kulkarni, D. V. R. N. Bhikshapathi +4

    МақолаChronic Lymphocytic Leukemia ResearchCurrent Research in Pharmacology and Drug Discovery20250 иқтибос

    ABIABI:AkademIndex/openalex/2025.article.000278

22. AML-095: Loss of Sex Chromosome in Acute Myeloid Leukemia

    Doskhan Orazkhanov, M Islamov, Zulkhumor Yunusova +1

    МақолаAcute Myeloid Leukemia ResearchClinical Lymphoma Myeloma & Leukemia20250 иқтибос

    ABIABI:AkademIndex/openalex/2025.article.003181

23. POSTER: AML-095 Loss of Sex Chromosome in Acute Myeloid Leukemia

    Doskhan Orazkhanov, M Islamov, Zulkhumor Yunusova +1

    МақолаChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20250 иқтибос

    ABIABI:AkademIndex/openalex/2025.article.008074

24. An odyssey of monoclonal gammopathies: focusing on precursors and the progression from MGUS and SMM to multiple Myeloma, with a brief overview of novel therapeutic strategies

    Xin Xin, Chunhui Fan, Ran Sheng +7

    МақолаMultiple Myeloma Research and TreatmentsClinical and Experimental Medicine20260 иқтибос

    ABIABI:AkademIndex/openalex/2026.article.000299

25. THE SIGNIFICANCE OF DRIVER GENE MUTATIONS JAK2, CALR, AND MPL IN CHRONIC MYELOPROLIFERATIVE DISEASES

    Beknur Bobir ugli Giyosov, Kodirjon Tukhtaboevich Boboev, Feruz Asatullaevich Daminov

    МақолаMyeloproliferative Neoplasms: Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 иқтибос

    ABIABI:AkademIndex/openalex/2026.article.000932